Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1647
-
Total 13F shares, excl. options
-
203M
-
Shares change
-
-5.15M
-
Total reported value, excl. options
-
$105B
-
Value change
-
-$2.5B
-
Put/Call ratio
-
0.98
-
Number of buys
-
789
-
Number of sells
-
-656
-
Price
-
$518.54
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2024
1,835 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q1 2024.
Elevance Health, Inc. - Common Stock (ELV) has 1,647 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 203M shares
of 226M outstanding shares and own 89.99% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21.2M shares), BlackRock Inc. (20.9M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.7M shares), STATE STREET CORP (10.5M shares), GEODE CAPITAL MANAGEMENT, LLC (4.69M shares), Sanders Capital, LLC (4.51M shares), WELLINGTON MANAGEMENT GROUP LLP (4.5M shares), FMR LLC (4.05M shares), AMERIPRISE FINANCIAL INC (3.6M shares), and Capital International Investors (3.5M shares).
This table shows the top 1647 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.